Singapore markets close in 1 hour 51 minutes

Repare Therapeutics Inc. (RPTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.9200-0.0700 (-1.75%)
At close: 04:00PM EDT
3.8700 -0.05 (-1.28%)
After hours: 06:34PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 166.39M
Enterprise value -67.84M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.71
Price/book (mrq)0.72
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 3-67.68%
S&P500 52-week change 323.23%
52-week high 313.8500
52-week low 32.9800
50-day moving average 33.5244
200-day moving average 35.9240

Share statistics

Avg vol (3-month) 3234.88k
Avg vol (10-day) 3201.96k
Shares outstanding 542.45M
Implied shares outstanding 642.45M
Float 817.64M
% held by insiders 10.95%
% held by institutions 193.76%
Shares short (15 May 2024) 4524.27k
Short ratio (15 May 2024) 41.43
Short % of float (15 May 2024) 42.05%
Short % of shares outstanding (15 May 2024) 41.24%
Shares short (prior month 15 Apr 2024) 4608.26k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -46.69%
Operating margin (ttm)20.64%

Management effectiveness

Return on assets (ttm)-14.75%
Return on equity (ttm)-18.91%

Income statement

Revenue (ttm)97.86M
Revenue per share (ttm)2.32
Quarterly revenue growth (yoy)822.90%
Gross profit (ttm)N/A
EBITDA -68.72M
Net income avi to common (ttm)-45.69M
Diluted EPS (ttm)-1.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)237M
Total cash per share (mrq)5.58
Total debt (mrq)2.78M
Total debt/equity (mrq)1.20%
Current ratio (mrq)8.33
Book value per share (mrq)5.47

Cash flow statement

Operating cash flow (ttm)-83.44M
Levered free cash flow (ttm)-74.77M